Open Access
BIO Web Conf.
Volume 86, 2024
International Conference on Recent Trends in Biomedical Sciences (RTBS-2023)
Article Number 01051
Number of page(s) 5
Published online 12 January 2024
  • S. Hanada, K. Fujioka, Y. Inoue, F. Kanaya, Y. Manome, K. Yamamoto. Cell-based in vitro blood–brain barrier model can rapidly evaluate nanoparticles’ brain permeability in association with particle size and surface modification. Int. J. of mol. sci. 15(2), (2014) [Google Scholar]
  • S. Wohlfart, S. Gelperina, J. Kreuter. Transport of drugs across the blood–brain barrier by nanoparticles. J. Cont. Rel., 161(2), (2012) [Google Scholar]
  • R.G. Pinheiro, A.J. Coutinho, M. Pinheiro, A.R. Neves. Nanoparticles for targeted brain drug delivery: what do we know?. Int. J. Mol. Sci. 22(21), 11654 (2021) [CrossRef] [Google Scholar]
  • P.R. Lockman, J.M. Koziara, R.J. Mumper, D.D. Allen. Nanoparticle surface charges alter blood–brain barrier integrity and permeability. J. drug targ. 12(9-10), 635-41, (2004) [CrossRef] [PubMed] [Google Scholar]
  • M.C. De Vries, E.E. Vaughan, M. Kleerebezem, W.M. de Vos. Lactobacillus plantarum—survival, functional and potential probiotic properties in the human intestinal tract. Int. Dairy J. 16(9), 1018-28, (2006) [CrossRef] [Google Scholar]
  • K. Kailasapathy, J. Chin. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immuno. cell bio. 78(1), 80-8, (2000) [CrossRef] [PubMed] [Google Scholar]
  • D. Bhargava, A. Deshpande, S. Thomas, Y. Sharma, P. Khare, S.K. Sahu, S. Dubey, A. Pandey, K. Sreekumar. High performance liquid chromatography determination of dexamethasone in plasma to evaluate its systemic absorption following intra-space pterygomandibular injection of twin-mix (mixture of 2% lignocaine with 1: 200,000 epinephrine and 4 mg dexamethasone): randomized control trial. Oral maxilla. surg. 20, 259-64, (2016). [CrossRef] [PubMed] [Google Scholar]
  • K.C. Baral, R. Bajracharya, S.H. Lee, H.K Han. Advancements in the pharmaceutical applications of probiotics: Dosage forms and formulation technology. Int. J. Nanomed. 16,7535, (2016) [Google Scholar]
  • S. Mukherjee, S. Ray, R.S. Thakur. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Pak J Pharm Sci. 22(2), 131-8, (2009) [Google Scholar]
  • M. Kouchak, and A. Azarpanah. “Preparation and in vitro evaluation of chitosan anoparticles containing diclofenac using the ion-gelation method”, Jundishapur J. Nat. Pharma. Prod. 10, No. 2, (2015). [Google Scholar]
  • M. Werle, H. Takeuchi. and A. Bernkop‐Schnürch. “Modified chitosans for oral drug delivery”, J. Pharma. Sci. 98(5), 1656, (2009) [Google Scholar]
  • N. Mohammadpourdounighi, A. Behfar, A. Ezabadi, H. Zolfagharian, M. Heydari. “Preparation of chitosan nanoparticles containing naja naja oxiana snake venom”, Nanomedicine: Nanotec. Bio. Med. 6(1), 137-143, (2010) [CrossRef] [Google Scholar]
  • D. Pandita, A. Ahuja, T. Velpandian, V. Lather, T. Dutta, R.K. Khar. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Die Pharmazie-An Int. J. Pharma. Sci. 64(5), 301-10, (2009) [Google Scholar]
  • K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, K. Mader. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 95 (2), 217–27, (2000) [Google Scholar]
  • D.M. Kim. Preparation of Smart Probiotic Solid Lipid Nanoparticles (SLN) for Target ontrolled Nanofood. Journal of Dairy Science and Biotechnology. 25(2), 5-10, (2007) [Google Scholar]
  • M.G.V Pinto, C.M Franz, U. Schillinger, W.H. Holzapfel. “Lactobacillus spp. With in vitro probiotic properties from human faeces and traditional fermented products”, Int. J. Food Microbio. 109(3), 205-214, (2006) [CrossRef] [Google Scholar]
  • M. Fernandez, S. Boris, C. Barbes. “Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract”, J. App. Microbio. 94(3), 449-455, (2003) [CrossRef] [PubMed] [Google Scholar]
  • V. Chandramouli, K. Kailasapathy, P. Peiris, M. Jones. “An improved method of microencapsulation and its evaluation to protect lactobacillus spp. In simulated gastric conditions”, J. Microbio. Methods. 56(1), 27-35, (2004) [CrossRef] [Google Scholar]
  • R.H. Müller, K. Mader, S. Gohla. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50(1), 161-177, (2000) [CrossRef] [Google Scholar]
  • M. Mehta, K.R. Paudel, S.D. Shukla, M.D. Shastri, S. Satija, S.K. Singh, M. Gulati, H. Dureja, F.C. Zacconi, P.M. Hansbro, D.K. Chellappan. Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: A PCR validation. Fut.Med. chem. 13(06), 543-9, (2021) [CrossRef] [PubMed] [Google Scholar]
  • Y. Kumari, S.K. Singh, R. Kumar, B. Kumar, G. Kaur, M. Gulati, D. Tewari, K. Gowthamarajan, V.N. Karri, C. Ayinkamiye, R. Khursheed. Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin. Int. J. Bio. Macromol. 149, 976-88, (2020) [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.